Sat-453 Emphysematous Pyelonephritis: Organ Threatening Infection Among Patients With Diabetes Mellitus

Abstract

with DM, 5 % CVA, 4.07 % CKD, 2.8 % with end stage kidney disease (ESKD), 2.5 % with lung disease, 1.49 % with infections and 0.53% with malignancy, as shown in table 2 and figure 2.Conclusions: SLE patients have a great burden of various medical comorbidities at time of diagnosis and hence may present with CKD, ESKD and even requiring renal replacement therapy at the initial encounter with health-care professionals. Strengthen the health system at primary level and education of public and health workforce is the main challenge to further reduce the risk of these comorbidities and the consequences.